Navigation Links
Mylan Launches Generic Version of Zyprexa® Tablets
Date:4/24/2012

PITTSBURGH, April 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg. This product is the generic version of Eli Lilly and Company's Zyprexa®, which is indicated for the treatment of schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar 1 disorder and maintenance treatment of bipolar 1 disorder. [1]

Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg, had U.S. sales of approximately $3.3 billion for the 12 months ending Dec. 31, 2011, according to IMS Health. Mylan is shipping this product immediately.

Currently, Mylan has 171 ANDAs pending FDA approval representing $97.2 billion in annual sales, according to IMS Health. Forty of these pending ANDAs are potential first-to-file opportunities, representing $25.7 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

[1] There is an increased
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
(Date:8/28/2014)... GA (PRWEB) August 28, 2014 AMTC graduate, rising ... was recently named one of the Top 10 finalists for ... has a chance to open for his mentor and coach from ... competing for the coveted opening slot on Thursday, August 28th at ... The winner at the competition will perform at the Gulf Coast ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Tea ... alliance with Gigya, the leader in Connected Consumer ... Tea Leaves will have the opportunity to build ... out who they are and how they like ... enables the world’s biggest brands to understand and ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 ChiLiving® ... 2014 in Asheville, NC at holistic retreat center, ... & ChiWalking founders, Katherine and Danny Dreyer, offers ... to learn techniques that support a lifetime of ... , Nestled in the heart of the ...
(Date:8/28/2014)... August 28, 2014 Alpine, NJ resident ... of his team, Zebras In Tiaras, to benefit the ... be held October 26, 2014 in Foley Square, New ... immunodeficiency community. Primary immunodeficiency diseases (PI) are a group ... which part of the body’s immune system is missing ...
(Date:8/28/2014)... Houston, Texas (PRWEB) August 28, 2014 ... Program. The program is a chance for regular customers ... MMAR Medical without the need for a wholesale license. ... athletics coaches, semi-professional athletic programs and others who regularly ... point. , “Whether supporting your own active lifestyle ...
Breaking Medicine News(10 mins):Health News:Rising Star Brandon Chase Named Finalist in Pepsi Southern Original Contest 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Join ChiRunning® & ChiWalking® Creators, Katherine and Danny Dreyer, for First-ever ChiWeekend Retreat in Asheville, NC 2Health News:Join ChiRunning® & ChiWalking® Creators, Katherine and Danny Dreyer, for First-ever ChiWeekend Retreat in Asheville, NC 3Health News:MMAR Medical Announces Customer Membership Program 2
... July 29 Cardica, Inc.,(Nasdaq: CRDC ) today announced ... and year ended June 30, 2008 on Tuesday, August,5, 2008 ... a,conference call at 4:30 p.m. Eastern Time to discuss the ... Conference Call Details, To access the live conference call ...
... July 29 DoctorDirectory.com, Inc.,announced that ... Inc. to,co-market VoSpire ER(R) (Albuterol Sulfate) ... solution. IncreaseRx utilizes,web-based educational and promotional ... of,interested prescribers with targeted sales and ...
... InfoLogix,s HealthTrax(TM) Wireless Asset Tracking Application Enables, 245-Bed ... Patient Care, HATBORO, Pa., July 29 ... provider of enterprise mobility and,advanced wireless asset tracking ... that it has been selected by,University Medical Center ...
... for Excellence Issue Brief, WASHINGTON, July 29 ... has issued its second issue brief on retiree,health ... Estimates,of Liabilities. The brief, which was written by ... and entrepreneurship in the,College of Management, North Carolina ...
... Each summer, as temperature and,humidity rise, mold ... U.S.,population is sensitive to mold, and invisible mold ... infections, according to the,American College of Allergy, Asthma ... building materials. In nature, mold breaks,down decaying organic ...
... Leading Jail Management Software Provider Pairs Up with Powerful Electronic ... ... PA (PRWEB) July 29, 2008 -- www.dsiiti.com [Digital ... Telephone Inc.] and www.coremr.com [CorEMR __title__ CorEMR] (Correctional ...
Cached Medicine News:Health News:Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008 2Health News:DoctorDirectory to Co-market VoSpire ER(R) with DAVA Pharmaceuticals, Inc. 2Health News:InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 2Health News:InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 3Health News:Financing Retiree Health Care: Assessing GASB 45 Estimates of Liabilities 2Health News:Creating a Healthy Home Environment: Mold and Mildew Free 2Health News:Partnership Improves Medical Records Management within Corrections Facilities 2Health News:Partnership Improves Medical Records Management within Corrections Facilities 3Health News:Partnership Improves Medical Records Management within Corrections Facilities 4Health News:Partnership Improves Medical Records Management within Corrections Facilities 5
... the newest peripheral nerve stimulator from B. Braun ... stimulators providing advanced digital technology. , ,Your ... HNS11 allows the localization of practically all mixed ... ,An additional optional component for the HNS11 ...
... system for the delivery and monitoring of ... system is a fully integrated, innovative instrument ... oxide therapy. The INOvent delivery system works ... anesthesia machine) to deliver a constant concentration ...
... a lightweight and large pore polypropylene mesh. Due ... to adapt to all movements taking place in ... with the large pores enables for idealhealing and ... ideal for incisional hernia repair and can also ...
... design and user-friendly set-up of the Mega Power ... the ground running. The confusion and frustration ... the past. Surgical teams have been asking ... use, and easy to set-up. The Mega ...
Medicine Products: